Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Internal and Emergency Medicine|November 1, 2024
Individuation of a cut-off value of triglyceride-glucose index for incident diabetes mellitus in patients with essential hypertensionMaria Perticone, Ermal Shehaj, Edoardo Suraci, et al.
Circulation|July 14, 2010
Endothelial dysfunction and subsequent decline in glomerular filtration rate in hypertensive patientsFrancesco Perticone, Raffaele Maio, Maria Perticone, et al.
Diabetes & Vascular Disease Research|June 27, 2012
Exenatide improves endothelial function assessed by flow mediated dilation technique in subjects with type 2 diabetes: results from an observational researchConcetta Irace, Simona De Luca, Ermal Shehaj, et al.
Giornale Italiano Di Cardiologia (2006)|February 28, 2023
[Renal effects of sodium-glucose cotransporter 2 inhibitors in patients with cardiovascular disease with and without chronic kidney disease]Manuela Benvenuto, Gaetano Panzarella, Ermal Shehaj, et al.
Biomedicines|June 27, 2024
Gut Permeability and Immune-Mediated Inflammation in Heart FailureMaria Perticone, Simona Gigliotti, Ermal Shehaj, et al.
Cardiovascular Diabetology|November 2, 2023
Sex-related differences for uric acid in the prediction of cardiovascular events in essential hypertension. A population prospective studyMaria Perticone, Raffaele Maio, Ermal Shehaj, et al.
Biomedicines|August 26, 2023
Mutual Effect Modification between Insulin Resistance and Endothelial Dysfunction in Predicting Incident Heart Failure in HypertensivesMaria Perticone, Raffaele Maio, Simona Gigliotti, et al.
International Journal of Cardiology|April 14, 2012
Endothelial dysfunction predicts regression of hypertensive cardiac massFrancesco Perticone, Raffaele Maio, Maria Perticone, et al.
Acta Diabetologica|August 22, 2012
Effect of normalization of fasting glucose by intensified insulin therapy and influence of eNOS polymorphisms on the incidence of restenosis after peripheral angioplasty in patients with type 2 diabetes: a randomized, open-label clinical trialPier Marco Piatti, Enrico Marone, Manuela Mantero, et al.
Pageof 1